Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in Japanese healthy adults: A Phase I study.

导出 OA

翻译打印收藏纠错

作者： Miwa,Haranaka ^[1] ; Makoto,Yono ^[2] ; Hiroyuki,Kishino ^[3] ; Rie,Igarashi ^[3] ; Nobuyuki,Oshima ^[3] ; Miyuki,Sawata ^[3] ; Heather Loryn,Platt ^[4]

作者单位： Department of Internal Medicine, SOUSEIKAI PS Clinic, Fukuoka, Japan. ^[1] Department of Urology, Nishi-Kumamoto Hospital, Souseikai, Kumamoto, Japan. ^[2] MSD K.K, Tokyo, Japan. ^[3] Merck & Co., Inc., Rahway, NJ, USA. ^[4]

关键词 21-valent Japanese V116 adults immunogenicity pneumococcal conjugate vaccine pneumococcal disease safety tolerability

主题词成年人(Adult);人类(Humans);疲劳(Fatigue);免疫球蛋白G(Immunoglobulin G);肺炎球菌感染(Pneumococcal Infections);疫苗, 结合(Vaccines, Conjugate);肺炎球菌菌苗(Pneumococcal Vaccines)

DOI 10.1080/21645515.2023.2228162

PMID 37389808

发布时间 2024-11-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交